References
Carr, A.A.: Haemodynamic and renal effects of a prostaglandin PgA1 in subjects with essential hypertension. American Journal of Medical Sciences 259: 21 (1970)
Collins, G.; Outerbridge, E.; Manku, M.S. and Horrobin, D.F.: Chloroquine as prostaglandin antagonist in treatment of patent ductus arteriosus. Lancet 2: 810 (1976)
Cotton, R.; Kovar, J.; Catterton, Z. et al.: Medical management of symptomatic ductus shunts in small preterm infants. Pediatric Research 10: 331 (1976)
Elliott, R.B.; Starling, M.B. and Neutze, J.M.: Medical manipulation of the ductus arteriosus. Lancet 1: 140 (1975)
Friedman, W.F.; Hirschklau, M.D.; Printz, M.P.; Pittick, P. and Kirkpatrick, S.E.: Pharmacological closure of patent ductus in the premature infant. New England Journal of Medicine 295: 526 (1976)
Heymann, M.A.; Rudolph, A.M. and Silverman, N.H.: Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. New England Journal of Medicine 295: 530 (1976)
Kitterman, J.A.; Edmunds, K.K. Jr.; Gregory, G.A. et al.: Patent ductus arteriosus in premature infants: Incidence, relation to pulmonary disease and management. New England Journal of Medicine 287: 473 (1972)
Starling, M.B. and Elliott, R.B.: The effect of prostaglandins, prostaglandin inhibitors, and oxygen on the closure of the ductus arteriosus, pulmonary arteries and umbilical vessels in vitro. Prostaglandins 8: 187 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lines, D.R. Breakthrough in Treatment of Patent Ductus Arteriosus. Drugs 13, 1–2 (1977). https://doi.org/10.2165/00003495-197713010-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197713010-00001